本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 证券代码：002795 证券简称：永和智控 公告编号：2023-060 永和流体智控股份有限公司 第五届监事会第七次临时会议决议公告 3、在提出本意见前，未发现参与第三季度报告编制和审议的人员有违反保 密规定的行为。 三、备查文件 《永和智控第五届监事会第七次临时会议决议》 特此公告。 永和流体智控股份有限公司监事会 2023 年 10 月 30 日 永和流体智控股份有限公司（以下简称"公司"）监事会于 2023 年 10 月 20 日以电话及邮件方式向全体监事发出召开第五届监事会第七次临时会议的通知。 2023 年 10 月 30 日，公司第五届监事会七次临时会议以通讯表决的方式召开。 本次会议应出席会议监事 3 名，实际出席会议监事 3 名，会议由监事会主席仲恒 女士召集。会议的召集、召开符合《中华人民共和国公司法》、《永和流体智控 股份有限公司章程》的有关规定。 二、监事会会议审议情况 以 3 票同意、0 票反对、0 票弃权的表决结果，审议通过了《公司 2023 年 第三季度报告》， ...

证券代码：002795 证券简称：永和智控 公告编号：2023-059 永和流体智控股份有限公司（以下简称"公司"）董事会于 2023 年 10 月 20 日以电话及邮件方式向全体董事发出召开第五届董事会第七次临时会议的通知。 2023 年 10 月 30 日，公司第五届董事会第七次临时会议以通讯表决的方式召开。 本次会议应出席董事 7 名，实际出席董事 7 名。会议由董事长魏璞女士召集。本 次会议的召集、召开程序符合《中华人民共和国公司法》、《深圳证券交易所股 票上市规则》和《公司章程》的有关规定。 二、董事会会议审议情况 在保证全体董事充分发表意见的前提下，本次会议形成如下决议： （一）以 7 票同意、0 票反对、0 票弃权的表决结果，审议通过了《公司 2023 年第三季度报告》。 具 体 内 容 详 见 公 司 于 2023 年 10 月 31 日 刊 登 于 巨 潮 资 讯 网 （http://www.cninfo.com.cn）、《证券时报》和《证券日报》的《公司 2023 年第 三季度报告》。 （二）以 7 票同意、0 票反对、0 票弃权的表决结果，审议通过了《关于公 司为控股孙公司融资授信额度提 ...

证券代码：002795 证券简称：永和智控 公告编号：2023-057 永和流体智控股份有限公司 关于控股股东、实际控制人部分股份质押展期的公告 公司控股股东、实际控制人曹德莅保证向本公司提供的信息内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 3、曹德莅资信状况良好，具备相应的资金偿还能力，所质押的股份不存在 平仓风险，股份质押风险在可控范围内。公司将持续关注其质押情况，并按规定 及时履行信息披露义务，敬请投资者注意投资风险。 股东名称 是否为控 股股东或 第一大股 东及其一 致行动人 本次质押 展期数量 （股） 占其所 持股份 比例 占公 司总 股本 比例 是否 为限 售股 是否 为补 充质 押 原质押起 始日 展期后质 押到期日 质权人 质押 用途 曹德莅 是 6,480,000 9.72% 1.45% 否 否 2022 年 9 月 29 日 2024 年 3 月 28 日 红塔证券 股份有限 公司 融资 质押 一、本次质押展期基本情况 | | | | | | 本次质 | 本次质 | 已质押股 ...

证券代码：002795 证券简称：永和智控 公告编号：2023-056 该笔股份质押剩余未解除质押部分，公司将在收到股东完成相关股份质押展 期通知后，再予以披露。 二、股东股份累计质押情况 公司控股股东、实际控制人曹德莅及股东余娅群为一致行动人关系。截至本 公告披露日，以上主体所持本公司股份累计质押情况如下： 永和流体智控股份有限公司 关于控股股东、实际控制人部分股份解除质押的公告 公司控股股东、实际控制人曹德莅保证向本公司提供的信息内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 永和流体智控股份有限公司（以下简称"公司"）于近日收到公司控股股东、 实际控制人曹德莅的通知，曹德莅已将其持有的本公司部分股份解除质押，相关 手续已在中国证券登记结算有限责任公司办理完毕。具体情况如下： 截至本公告披露日，上表中的质押主体所质押的股份不存在平仓风险，股份质 押事项对上市公司生产经营、公司治理等不会产生影响，质押的股份不涉及业绩 补偿义务。公司将持续关注其质押情况，并按规定及时履行信息披露义务，敬请 投资者注 ...

永和流体智控股份有限公司2023年半年度报告全文 永和流体智控股份有限公司 2023 年半年度报告 2023 年 8 月 ...

永和流体智控股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------------------|----------------------------------|---------------------------| | | | 编号：2023-002 | | | | 特定对象调研 □分析师会议 | | | □媒体采访 □业绩说明会 | | | 投资者关系活动类别 | □新闻发布会 □路演活动 | | | | □现场参观 | | | | □其他 | | | | 中国国际金融股份有限公司 | 胡子慧、张杰敏 | | | 天风（上海）证券资产管理有限公司 | 吴鑫涛 | | | 浙商证券股份有限公司 | 谢金翰 | | | 上海贤盛投资管理有限公司 | 马彦仁 | | | 华安财保资产管理有限责任公司 | 徐梓倩 | | 参与单位名称及人员姓名 | | | | | 财通证券股份有限公司 | 陆彦蓉 陈思雨 | | | 上海宝源胜知投资管理有限公司 | 王耿耿 | | | 东方财富信息股份有限公司 | 唐硕 | | | 财通证券股份有限公司 | 何兵 | | | 中 ...

证券代码：002795 证券简称：永和智控 公告编号：2023-035 永和流体智控股份有限公司 关于参加浙江辖区上市公司 2023 年投资者网上集体接待日 活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，永和流体智控股份有限公司（以下简称 "公司"）将参加由浙江证监局、浙江省上市公司协会与深圳市全景网络有限公 司联合举办的"2023 年浙江辖区上市公司投资者集体接待日活动"，现将相关 事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP, 参与本次互动交流，活动时间为 2023 年 5 月 12 日（周五）15:00-17:00。届时 公司高管将在线就公司 2022 年度业绩、公司治理、发展战略、 经营状况、融资 计划、股权激励和可持续发展等投资者关心的问题，与投资者进行沟通与交流， 欢迎广大投资者踊跃参与！ 特此公告！ 永和流体智控股份有限公司董事会 2023 年 5 月 9 日 ...

Financial Performance - The company's operating revenue for 2022 was ¥989,736,616.68, a decrease of 1.86% compared to ¥1,008,508,895.38 in 2021[6]. - The net profit attributable to shareholders was -¥26,703,315.88 in 2022, representing a decline of 242.93% from ¥18,682,917.51 in 2021[6]. - The net profit after deducting non-recurring gains and losses was -¥23,236,427.00, down 258.01% from ¥14,705,244.35 in the previous year[6]. - The total profit amounted to -10.07 million yuan, representing a decline of 127.63% year-on-year[56]. - Total revenue for 2022 was approximately ¥989.74 million, a decrease of 1.86% compared to ¥1,008.51 million in 2021[76]. - The industrial segment revenue decreased by 8.22% to ¥842.85 million, while medical services and other industries saw a significant increase of 62.87% to ¥146.89 million[76]. - The company reported a net profit of -29,419,229.42 yuan for the year 2022, resulting in a total distributable profit of 57,288,351.36 yuan[182]. - The cash dividend total for the reporting period was 0 yuan, reflecting the company's negative net profit and lack of distributable profit[181]. Cash Flow and Assets - The net cash flow from operating activities increased by 83.67% to ¥211,517,475.65, compared to ¥115,162,707.14 in 2021[6]. - The total assets at the end of 2022 were ¥1,548,725,920.03, an increase of 2.80% from ¥1,506,596,737.33 at the end of 2021[6]. - Cash and cash equivalents increased by 767.10% to CNY 171,556,346.50 from CNY 19,785,081.83 in 2021[92]. - Cash and cash equivalents represented 21.51% of total assets, up from 8.76% at the beginning of the year, indicating improved liquidity[96]. - The company's fixed assets decreased by 2.30% to CNY 432,974,178.84 from CNY 455,901,734.73 in the previous year[96]. Business Operations and Strategy - The company operates in various sectors, including medical technology and fluid control systems[19]. - The company is expanding into the photovoltaic battery industry while continuing to develop its tumor precision radiotherapy and valve plumbing businesses[33]. - The company has established a chain of specialized hospitals for tumor precision radiotherapy, with advanced medical imaging and treatment equipment[46]. - The company plans to expand its tumor precision radiotherapy services and improve treatment capabilities in response to market demands[51]. - The company aims to improve patient satisfaction and service quality through comprehensive healthcare management and service reforms[57]. - The company is strategically focusing on high-value cities and emerging markets to expand its chain of specialized hospitals in cancer treatment[62]. - The company plans to enter the photovoltaic manufacturing sector, focusing on high-efficiency N-type TOPCon battery production and expanding its market share in large-scale solar projects[115]. Research and Development - Research and development expenses rose by 19.47% to ¥22.35 million, reflecting the company's commitment to innovation[85]. - The company has developed 57 intellectual property rights related to TOPCon and IBC battery technologies, enhancing its competitive edge in the photovoltaic sector[71]. - The number of R&D personnel increased by 16.30% from 92 in 2021 to 107 in 2022, with R&D personnel accounting for 8.09% of the total workforce[90]. - R&D investment increased by 19.47% from ¥18,710,677.24 in 2021 to ¥22,353,952.01 in 2022, representing 2.26% of operating revenue[91]. Corporate Governance - The company has established a fair and transparent performance evaluation and incentive mechanism for directors and senior management, enhancing operational efficiency[135]. - The company maintains independence from its controlling shareholder in business, personnel, assets, and finance, ensuring no competitive conflicts exist[131]. - The company has a complete and independent business system, capable of making autonomous operational decisions without reliance on the controlling shareholder[141]. - The company has implemented a strict insider information management system, with no violations reported during the reporting period[138]. - The company has established a robust internal control system, including internal audit regulations, to ensure compliance and financial decision-making independence[145]. Market Trends and Challenges - The demand for tumor medical services is expected to grow, with an estimated 499,000 new cancer cases projected in China by 2024[34]. - The market size for precision radiotherapy in China reached 37.5 billion CNY in 2021, with a CAGR of 15.6% from 2016 to 2021, expected to grow to 80.9 billion CNY by 2025[36]. - The company anticipates increased competition in the solar energy sector, which may pressure its market expansion and project profitability[124]. - The photovoltaic industry is experiencing a phase of structural overcapacity, with leading companies accelerating capacity expansion to maintain market share[125]. Employee and Talent Management - The total number of employees at the end of the reporting period was 1,322, with 1,309 from major subsidiaries[174]. - The company emphasizes internal talent development and has established a comprehensive training plan to enhance employee capabilities[177]. - The company has implemented a differentiated compensation model based on employee levels and categories[175]. - The company ensures that employee income growth aligns with overall company performance to maintain cost control[176]. Shareholder Engagement - The company has established a three-year shareholder return plan (2022-2024) to ensure a scientific, sustainable, and stable return mechanism for shareholders[179]. - The company is committed to ensuring that minority shareholders' rights are fully protected and that the decision-making process for dividends is transparent and compliant[180]. - The company held several shareholder meetings in 2022, with participation rates ranging from 4.37% to 25.95%[147].

Financial Performance - The company's revenue for Q1 2023 was ¥240,508,189.75, a decrease of 3.81% compared to ¥250,022,104.21 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥15,761,930.05, representing a decline of 226.32% from a profit of ¥12,478,199.47 in the previous year[5] - The net profit for the first quarter of 2023 was -¥19,511,612.42, a significant decline compared to a net profit of ¥10,909,591.98 in the same period last year, representing a year-over-year decrease of approximately 278%[28] - The total revenue from operating activities was ¥204,533,780.17, down from ¥280,781,176.65 in the previous year, indicating a decrease of about 27%[29] - The total profit before tax was -¥17,597,176.53, a sharp decline from ¥16,069,608.62 in the same quarter last year[28] - Basic and diluted earnings per share were both -¥0.05, down from ¥0.04 in the previous year[29] - The company reported a total comprehensive income of -¥19,587,537.53 for the first quarter, compared to ¥10,876,464.25 in the same quarter of the previous year[28] Cash Flow and Financing - The net cash flow from operating activities was -¥55,885,814.43, a decrease of 182.18% compared to ¥68,005,318.04 in the same period last year[13] - The cash flow from financing activities increased by 78.52% to ¥186,142,548.43, driven by increased investments and loans received[13] - The financing activities generated a net cash inflow of ¥186,142,548.43, compared to ¥104,270,079.64 in the previous year, indicating a year-over-year increase of approximately 78.5%[30] - The company experienced a significant increase in investment cash outflow, totaling -¥138,195,439.32 compared to -¥20,697,964.31 in the same period last year[30] Assets and Liabilities - Total assets increased by 8.11% to ¥1,674,250,251.56 from ¥1,548,725,920.03 at the end of the previous year[5] - The total current asset balance was CNY 679,619,915.80, up from CNY 671,462,543.99 at the beginning of the year[24] - The total non-current assets increased to CNY 994,630,335.76 from CNY 877,263,376.04 at the beginning of the year[24] - Total liabilities amounted to CNY 768,696,273.90, an increase from CNY 725,723,536.23 at the beginning of the year[25] - The company's total assets reached CNY 1,674,250,251.56, up from CNY 1,548,725,920.03 at the beginning of the year[25] - Short-term borrowings rose to CNY 247,442,224.34 from CNY 186,396,068.72 at the beginning of the year[24] Expenses - The company reported a significant increase in management expenses, which rose by 99.70% to ¥43,771,079.78 due to stock incentive costs and increased service fees[12] - Research and development expenses increased by 35.89% to ¥7,418,146.32, indicating a focus on innovation[12] - Total operating costs increased to CNY 255,730,836.66, up 12.19% from CNY 227,957,935.87 in the previous period[27] - Research and development expenses rose to CNY 7,418,146.32, an increase of 35.83% compared to CNY 5,459,065.78 in the previous period[27] Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,131[14] - The largest shareholder, Cao Deli, holds 14.95% of the shares, totaling 47,600,000 shares, with 25,592,000 shares pledged[14] - The second-largest shareholder, Chen Xianyun, holds 7.34% of the shares, totaling 23,369,360 shares[14] Corporate Governance - The company completed the election of the fifth board of directors and the fifth supervisory board, appointing Wei Pu as the chairman[16] - The company approved the cancellation of 770,000 stock options from the 2019 stock option incentive plan that were not exercised by two departed employees[17] - The company decided to repurchase and cancel 16,800 restricted stocks from the 2022 incentive plan that were not unlocked for two departed employees[18] Acquisitions - The company’s wholly-owned subsidiary, Zhejiang Yonghe Intelligent Control Technology Co., Ltd., acquired assets from Zhiba Technology for RMB 33.9 million, including production equipment and corresponding intellectual property[20] - The acquisition has been completed, including asset inventory and payment as per the agreement[21] Other Income - The company reported a decrease in other income, which was ¥721,311.58 compared to ¥272,236.07 in the previous year, a decline of about 64%[28]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 永和流体智控股份有限公司（以下简称"公司"）《2022 年年度报告》已于 2023 年 4 月 29 日公开披露。为了让广大投资者能进一步了解公司 2022 年年度 报告和经营情况，公司将于 2023 年 5 月 16 日（星期二）下午 15：30-17：00 举 办 2022 年度网上业绩说明会。本次年度业绩说明会将通过深圳证券交易所提供 的"互动易"平台采用网络远程的方式举行，投资者可登录深圳证券交易所"互动 易"平台（http://irm.cninfo.com.cn），进入"云访谈"栏目参与本次年度业绩说明会。 出席本次年度业绩说明会的人员有：公司董事长魏璞女士，董事、副总经理 兼董事会秘书刘杰先生，独立董事盛毅先生，财务总监廖丽娜女士。（如有特殊 情况，参会人员会有调整） 为充分尊重投资者、提升公司与投资者之间的交流效率及针对性，现就公司 本次业绩说明会提前向投资者公开征集问题，提问通道 2023 年 5 月 11 日起开放， 投资者可提前进入深圳证券交易所"互动易"平台(http://irm.cninf ...